PPARGC1A and melanoma: Conversely, the melanoma cells expressing low PGC-1α levels are more glycolytic and vulnerable to ROS-inducing drugs.327 Intriguingly, the heterogeneous expression of PGC-1α within tumors leads to differences in their ability to proliferate or invade.